Log in

Relevant bibliographies by topics / Hematology-oncology

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Hematology-oncology'

Author: Grafiati

Published: 4 June 2021

Last updated: 27 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hematology-oncology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hematology-oncology"

1

Richardson, Paul. "Hematology/Oncology." Journal of Oral and Maxillofacial Surgery 63, no. 8 (2005): 16. http://dx.doi.org/10.1016/j.joms.2005.05.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Moynihan, Timothy J. "Hematology-Oncology Therapy." Mayo Clinic Proceedings 82, no. 7 (2007): 896. http://dx.doi.org/10.4065/82.7.893-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nalley, Catlin. "Pediatric Hematology/Oncology." Oncology Times 42 (March 2020): 1–3. http://dx.doi.org/10.1097/01.cot.0000658652.86745.82.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hughes, Walter T. "Oncology and hematology." Current Opinion in Pediatrics 2, no. 1 (1990): 110–12. http://dx.doi.org/10.1097/00008480-199002000-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pritchard, J., and I. M. Hann. "Oncology and hematology." Current Opinion in Pediatrics 2, no. 1 (1990): 113–15. http://dx.doi.org/10.1097/00008480-199002000-00022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Cohen, Alan R., and Beverly J. Lange. "Hematology and oncology*." Current Opinion in Pediatrics 3, no. 1 (1991): 79–86. http://dx.doi.org/10.1097/00008480-199102000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Hematology and oncology." Current Opinion in Pediatrics 4, no. 1 (1992): 167–92. http://dx.doi.org/10.1097/00008480-199202000-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mentzer, William C., and Beverly J. Lange. "Hematology and oncology*." Current Opinion in Pediatrics 5, no. 1 (1993): 69–73. http://dx.doi.org/10.1097/00008480-199302000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mentzer, William C., and Katherine Matthay. "Hematology and oncology." Current Opinion in Pediatrics 7, no. 1 (1995): 33–35. http://dx.doi.org/10.1097/00008480-199502000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Newburger, Peter E. "Hematology and oncology." Current Opinion in Pediatrics 11, no. 1 (1999): 31–32. http://dx.doi.org/10.1097/00008480-199902000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Hematology-oncology"

1

Maxfield, Melissa D. "Hematology/Oncology Unit Champions Promote Care Plans for CLABSI Prevention." Mount St. Joseph University Dept. of Nursing / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=msjdn1619082600353203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Thomas, C. M., and John B. Bossaer. "Patient Use of Herbal Supplements in an Outpatient Hematology/Oncology Medical Clinic." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etsu-works/2356.

Full text

Abstract:

Primary Objective: According to the National Center for Health Statistics, many Americans use some type of vitamin or supplement. A recent study of cancer patients in the VA medical system found that a significant number of cancer patients do not mention the use of supplements to their healthcare providers. Many of these supplements were also found to interact with or compound side effects of chemotherapy regimens. The purpose of this study is to determine the incidence of cancer patients taking supplements and to determine the completeness of home medication lists in regard to vitamins or her

APA, Harvard, Vancouver, ISO, and other styles

3

Soell, Kurt D. "Spirituality and Depression in Parents with Children in Oncology or Hematology Treatment." ScholarWorks, 2011. https://scholarworks.waldenu.edu/dissertations/938.

Full text

Abstract:

The psychological burden of cancer treatment affects not only child patients but also their parents. There is extensive literature on the positive influence of spirituality on the cancer patient. But there is a gap in the literature on the potential healing influence of spirituality on the parent of the cancer or hematology patient. The purpose of this study was to examine the relationship between spirituality and parents' levels of depression and anxiety during their child's hematological or oncology treatment. Using the transtheoretical model of change, a purposive sample of 48 parents of

APA, Harvard, Vancouver, ISO, and other styles

4

Tawadros, Fady, and Kanishka Chakraborty. "Systemic Mastocytosis with associated CMML." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/75.

Full text

Abstract:

Systemic mastocytosis refers to a heterogeneous group of clinical disorders characterized by excessive mast cell accumulation in one or multiple organs. Mastocytosis is now considered as a separate disease category in the 2016 WHO classification of myeloid neoplasm and acute leukemia. It is no longer considered as a subgroup of meyloproliferate neoplasms. The clinical presentation of mastocytosis is heterogeneous ranging from skin-limited disease (cutaneous mastocytosis) to a more aggressive form with extra cutaneous presentation (systemic mastocytosis) with or without skin involvement. We ar

APA, Harvard, Vancouver, ISO, and other styles

5

REDDY, DHEERAJ MD, Fady MD Tawadros, Archi MD Patel, and Devapiran MD Jaishankar. "RENAL AND TESTICULAR MYELOID SARCOMA DEFINES ACUTE MYELOID LEUKEMIA EVEN IN THE ABSENCE OF BLOOD AND MARROW INVOLVEMENT." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/211.

Full text

Abstract:

Acute Myeloid Leukemia (AML) is an aggressive hematopoietic neoplasm characterized by rapid clinical progression and universally fatal outcome if left untreated. The neoplastic cells are immature precursor cells that usually originate in the bone marrow and are often noted in the peripheral circulation. Myeloid sarcomas are rare abnormal collection of these cells in extramedullary sites and are now defined as a unique subset of AML as per the WHO classification. Here we describe a patient with AML presenting with a renal and testicular mass, which on biopsy revealed myeloid sarcoma in the abse

APA, Harvard, Vancouver, ISO, and other styles

6

Singal, Sakshi, Rossa Khalaf, Sara Masood, and Devapiran Jaishankar. "BURKITT’S LYMPHOMA MASQUERADING AS ACUTE CHOLECYSTITIS AND VAGINAL BLEEDING." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/11.

Full text

Abstract:

Burkitt lymphoma is a highly aggressive B cell non-Hodgkin lymphoma characterized by the translocation t(8,14) and deregulation of the MYC gene on chromosome 8. The endemic (African) form presents classically as an expanding mass in the jaw. The nonendemic (European/North American) form often presents with an abdominal mass. We present an interesting case of Burkitt’s Lymphoma with atypical features. A thirty-five-year-old lady with no significant medical history presented to the hospital with a three week complaint of vaginal bleeding and lower abdominal pain/cramps associated with night swea

APA, Harvard, Vancouver, ISO, and other styles

7

Montanari, Pierre. "Étude des kinases PIMs dans l’érythropoïèse normale et pathologique." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB094.

Full text

Abstract:

L’érythropoïèse désigne l’ensemble des phénomènes de prolifération et de maturation qui permettent d’obtenir les globules rouges à partir de cellules souches médullaires. C’est un processus de différenciation continue qui génère des cellules érythroïdes de plus en plus matures. L’érythropoïétine (EPO) est le principal régulateur de l’érythropoïèse. En effet, il est indispensable à la survie et à la prolifération des progéniteurs érythroïdes et des précurseurs érythroblastiques. Le rôle des Pims kinases dans la régulation de l'érythropoïèse n’a pas été étudié bien qu’il ait été montré que les s

APA, Harvard, Vancouver, ISO, and other styles

8

Vedantam, Venkata Sri Harsha, Neethu Nair, CHRISTINE MOORE, and Diana Gorman-Nunley. "VITAMIN B12 DEFICIENCY ANEMIA-ASSOCIATED MALIGNANCY ACCELERATED BY SUPPLEMENTATION." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/49.

Full text

Abstract:

Vitamin B12 and folate are necessary for bone marrow progenitor growth and division. Deficiencies are common in lymphoproliferative disorders due to increased demands of rapidly growing malignant cells. Isolated vitamin B12 deficiency is seen in 13% of these patients and may be their only manifestation. We present the case of vitamin B12 deficiency anemia due to an underlying malignancy that was discovered following supplementation. A 77-year-old nonsmoker female with chronic kidney disease and hypothyroidism presented to her internist with dyspnea, tachycardia and unintentional 7-pound weight

APA, Harvard, Vancouver, ISO, and other styles

9

Schäfer, Louisa [Verfasser], Jutta [Gutachter] Hübner, Michael [Gutachter] Hartmann, and Franz-Josef [Gutachter] Prott. "Potential interactions of medication prescribed in discharge letters from a clinic for hematology and oncology / Louisa Schäfer ; Gutachter: Jutta Hübner, Michael Hartmann, Franz-Josef Prott." Jena : Friedrich-Schiller-Universität Jena, 2020. http://d-nb.info/1218595663/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Singh, Kanwardeep, Vindhya Sriramoju, Sakshi Singal, Elnora N. Spradling, and Rabia Zafar. "A case of Progressive Glomerulonephritis with Monoclonal Immunoglobulin Lambda Light Chain Deposition (LCDD)." Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/asrf/2018/schedule/77.

Full text

Abstract:

Light Chain Deposition Disease (LCDD) is a type of monoclonal immunoglobulin deposition disease characterized by the non-amyloid deposition of monoclonal light chains in the tubular basement membranes and Bowman’s capsule. It was first described about 3 decades ago, but due to varied clinical presentations, many differential diagnoses and low incidence, it is both underrecognized and underreported. We present a case of 85-year-old female with past medical history significant for CKD and HTN, who presented with accelerated HTN, normocytic anemia and worsening renal function. Laboratory data sho

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Hematology-oncology"

1

O'Connell, Casey. Hematology and oncology. Blackwell Pub., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

M, Boyiadzis Michael, ed. Hematology-oncology therapy. McGraw-Hill, Medical Pub. Division, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

C, Walters Mark, Vichinsky Elliott P, and Feusner James, eds. Pediatric hematology/oncology. Saunders, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

E, Wood Marie, ed. Hematology/oncology secrets. 2nd ed. Hanley & Belfus, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wood, Marie E. Hematology/oncology secrets. Hanley & Belfus, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Estlin, Edward J., Richard J. Gilbertson, and Robert F. Wynn, eds. Pediatric Hematology and Oncology. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444315134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Longo, Dan L. Harrison's hematology and oncology. Edited by Harrison Tinsley Randolph 1900-1978. McGraw-Hill Medical, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

A, Danso Michael, and Basch Ethan M, eds. Hematology and oncology pearls. Elsevier Mosby, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Berdel, W. E., Th Büchner, J. Kienast, et al., eds. Transplantation in Hematology and Oncology. Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-59592-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

B, Caughey Aaron, ed. Pathophysiology.: Renal, hematology, and oncology. Blackwell Pub., 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Hematology-oncology"

1

Holzman, Robert S., Thomas J. Mancuso, Navil F. Sethna, and James A. DiNardo. "Hematology/Oncology." In Pediatric Anesthesiology Review. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1617-4_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mancuso, Thomas J. "Hematology/Oncology." In Pediatric Anesthesiology Review. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-60656-5_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ebell, Mark H. "Hematology/Oncology." In Evidence-Based Diagnosis. Springer New York, 2001. http://dx.doi.org/10.1007/978-1-4757-3514-7_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mancuso, Thomas J. "Hematology/Oncology." In Pediatric Anesthesiology Review. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48448-8_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sinha, Arpan A., Scott Moerdler, Ellen Fraint, Adit Tal, Nora E. Rahmani, and Kerry Morrone. "Hematology/Oncology." In Pediatric Board Study Guide. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21267-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Buttaro, Terry Mahan. "Hematology/Oncology." In Nursing Care of the Hospitalized Older Patient. John Wiley & Sons, Ltd.,, 2013. http://dx.doi.org/10.1002/9781118704769.ch11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ajebade, Opeyemi, Katrina Blankenhorn, Zoe King, and Kerry Morrone. "Hematology/Oncology." In Pediatric Board Study Guide. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-65148-9_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jain, Rajiv, and Delmar Short. "Hematology and Oncology." In Primary Care Medicine for Psychiatrists. Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5857-6_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hubbard, John R., and Robert P. Albanese. "Hematology and Oncology." In Primary Care Medicine for Specialists and Non-Specialists. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0709-3_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Marneni, Shashidhar Rao, and Haamid Chamdawala. "Hematology and Oncology." In Prepare for the Pediatric Emergency Medicine Board Examination. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-28372-8_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hematology-oncology"

1

Nitsch, Thorsten, Julia Lanznaster, and Thomas Südhoff. "Ultrasound guided biopsy in hematology and oncology." In 46. Dreiländertreffen der DEGUM in Zusammenarbeit mit ÖGUM & SGUM. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1772355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Oprea, Tudor, Mohammed Quazi, Suman Sirimulla, Alexei Pushechnikov, and Nikolay Savchuk. "Using Artificial Intelligence to Uncover Novel Therapeutic Targets in Hematology/Oncology." In ASPET 2024 Annual Meeting Abstract. American Society for Pharmacology and Experimental Therapeutics, 2024. http://dx.doi.org/10.1124/jpet.250.100128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Moldwin, Zachary H., Andrew Malty, Donna R. Rivera, et al. "Abstract 27: Getting granular: A structured database of doses and schedules in hematology/oncology." In Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies; January 9-12, 2020; San Diego, CA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1557-3265.advprecmed20-27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bender, Julia L. Glade, Jennifer A. Oberg, Maria Luisa Sulis, et al. "Abstract PR01: Precision in Pediatric Sequencing (PIPseq): Clinical implementation of genomic sequencing into pediatric hematology-oncology practice." In Abstracts: AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy; June 13-16, 2015; Salt Lake City, UT. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3265.pmsclingen15-pr01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Komotskiy, E. I., B. A. Fadichev, and M. A. Medvedeva. "Analysis of the Russian scientific environment in terms of hematology oncology using machine learning methods and social graphs." In INTERNATIONAL CONFERENCE OF NUMERICAL ANALYSIS AND APPLIED MATHEMATICS ICNAAM 2021. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0163218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mazzocco, M., R. Mura, R. De Santis, et al. "Lymphocyte-Predominant Hodgkin Lymphoma Variant: Long Term Outcome. Data From The Lh-2004 Protocol Of The Italian Association Of Pediatric Hematology And Oncology (Aieop)." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701829.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lopez-F, N. A., and M. L. Ortiz. "Clinical course and prognosis of children with Hodgkin Lymphoma in Central and Southern Mexico areas. Results of the Mexican Association of Pediatric Hematology and Oncology." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701833.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Martin, Richard L., Michael Grant, Rushad Patell, et al. "Abstract PO-018: Hematology oncology COllaborative VIDeoconferencing (COVID) Learning Initiative: A multi-institutional trainee alliance to rapidly disseminate emerging SARS-CoV2 and cancer best practices." In AACR Virtual Meeting: COVID-19 and Cancer; July 20-22, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1557-3265.covid-19-po-018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bourbeau, Brian, Mou Guharoy, Elizabeth Garrett-Mayer, et al. "Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network." In AACR Virtual Meeting: COVID-19 and Cancer; July 20-22, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1557-3265.covid-19-po-022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mukherjee, Kalyan K., Debasish Banerjee, Anjan Das, et al. "Significance of Detecting Minimal Residual Disease by Flow Cytometry and its Impact on Overall Survival and Prognosis of Pediatric B-Cell ALL Patient Experience from a Tertiary Care Centre in Eastern India." In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735366.

Full text

Abstract:

Abstract Introduction The improved prognosis of pediatric B-cell acute lymphoblastic leukemia (pBALL) is considered as a good progress of medical science in the field of oncology and hematology. Minimal residual disease (MRD) refers to presence of disease in molecular level is a newer practice with respect to the detection of complete remission by conventional pathologic analysis. Prognostic value of MRD in pediatric ALL (p-ALL) is well known. Objectives This study was aimed to describe clinical outcomes and prognosis, that is, overall survival and relapse in the patients with pBALL with respe

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hematology-oncology"

1

Lin, Zhijuan, Xing Chen, Long Liu, Zhifeng Li, and Bing Xu. Chemo-Free Treatments in Relapsed and/or Refractory Follicular Lymphoma: A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0111.

Full text

Abstract:

Review question / Objective: FL is the most common indolent B cell lymphoma worldwide and patients with FL always have long term survival. However, advanced FL remains incurable and there is no universal agreement on optimal regimen to manage relapsed FL. Condition being studied: The efficacy of chemo-free regimens, including CD20 antibodies and targeted agents, in relapsed and/or refractory Follicular lymphoma. Information sources: We used the MEDLINE, Embase, and Cochrane Library databases to search the RCTs met our selection criteria. We also searched clinicalTrials.gov and the internationa

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!